NCT05298709 2025-06-11
Functional Magnetic Resonance Imaging (fMRI) Vascular Reactivity in Cerebral Cavernous Malformations (CCM)
University of New Mexico
Phase NA Terminated
Clinical Trials
4 trialsNCT03474614 2024-04-19
Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation
St. Joseph's Hospital and Medical Center, Phoenix
Phase 2 Terminated
NCT01764451 2024-03-12
Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins
University of New Mexico
Phase EARLY_PHASE1 Terminated
NCT05148663 2023-09-01
CCM Blood Biomarker Validation Study
Texas Tech University Health Sciences Center, El Paso
Terminated